MedTrace Logo

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)

NCT02166424 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2017-12-21

No results posted yet for this study

Summary

The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.

Conditions

Interventions

DIETARY_SUPPLEMENT

Omega-3 polyunsaturated fatty acids

DIETARY_SUPPLEMENT

Olive oil

Sponsors & Collaborators

  • China Medical University, Taiwan

    collaborator OTHER

  • Japan Society for the Promotion of Science (JSPS)

    collaborator UNKNOWN

  • University of Toyama

    collaborator OTHER

  • Chiba University

    collaborator OTHER

  • National Center for Child Health and Development

    collaborator UNKNOWN

  • Tokyo Medical University

    lead OTHER

Principal Investigators

  • Daisuke Nishi, M.D., Ph.D. · Tokyo Medical University

  • Kuan-Pin Su, M.D., Ph.D. · China Medical Univeristy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2017-08-31
Completion
2017-12-31

Countries

  • Japan
  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02166424 on ClinicalTrials.gov